2m 2m 2m 2m 2m 2m 2m
REZOLUTE (RZLT)
NASDAQ
$4.01-$0.07 (-1.60%)
Price as of Oct 02, 2026 5:01 PM EDT- $391.9MMarket Cap
- -55.71%1-Year Change
- BiotechnologyIndustry
REZOLUTE (RZLT)
$4.01-$0.07 (-1.60%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -53.8M -12.56% | -61.5M +10.38% | -55.7M +27.23% | -43.8M +34.87% | |
Depreciation and Amortization Expense | 31,000 0.00% | 31,000 -13.89% | 36,000 +20.00% | 30,000 +130.77% | |
Total Operating Expenses | 83.0M +3.85% | 79.9M +13.45% | 70.4M +25.78% | 56.0M +33.81% | |
Operating Profit | -83.0M +3.85% | -79.9M +13.45% | -70.4M +25.78% | -56.0M +33.81% | |
Interest Income | 5.4M -1.86% | 5.5M +12.57% | 4.9M +15.73% | 4.2M +5,160.00% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -1.8M 0.00% | |
Interest Income and Expense and Net | 5.4M -1.86% | 5.5M +12.57% | 4.9M +102.83% | 2.4M +239.03% | |
Total Nonoperating Income and Expense | 5.4M -1.86% | 5.5M +179.12% | 2.0M -53.27% | 4.2M +436.78% | |
Income before Taxes | -83.0M +3.85% | -79.9M +13.45% | -70.4M +25.78% | -56.0M +33.81% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -77.6M +4.27% | -74.4M +8.70% | -68.5M +32.19% | -51.8M +26.13% | |
Net Income from Continuing Operations Applicable to Common | -77.6M +4.27% | -74.4M +8.70% | -68.5M +32.19% | -51.8M +26.13% | |
Basic EPS and Net Income | -0.75 -23.47% | -0.98 -26.32% | -1.33 +31.68% | -1.01 -55.31% | |
Diluted EPS and Net Income | -0.75 -23.47% | -0.98 -26.32% | -1.33 +31.68% | -1.01 -56.47% | |
Basic Weighted Average Shares | 103.9M +36.72% | 76.0M +47.67% | 51.5M +0.54% | 51.2M +181.29% | |
Diluted Weighted Average Shares | 103.9M +36.72% | 76.0M +47.67% | 51.5M +0.54% | 51.2M +162.67% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 10.6M -88.72% | 94.1M +33.68% | 70.4M +338.99% | 16.0M -89.34% | |
Short-Term Investments | 97.2M +31.78% | 73.8M +30.58% | 56.5M -34.22% | 85.9M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 107.8M -35.78% | 167.9M +32.30% | 126.9M +24.51% | 101.9M -32.25% | |
Total Current Assets | 110.5M -35.43% | 171.1M +33.03% | 128.7M +22.63% | 104.9M -31.03% | |
Accumulated Depreciation | 169,000 +22.46% | 138,000 +28.97% | 107,000 +50.70% | 71,000 +77.50% | |
Property and Plant and Equipment and Net | 41,000 -43.06% | 72,000 -30.10% | 103,000 -25.90% | 139,000 +768.75% | |
Total Long-Term Assets | 41,000 -87.76% | 335,000 -8.47% | 366,000 -97.80% | 16.6M +103,706.25% | |
Total Assets | 112.8M -35.69% | 175.5M +32.21% | 132.7M +7.29% | 123.7M -18.83% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.4M -4.15% | 11.9M +24.01% | 9.6M +84.73% | 5.2M +111.21% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 276,000 -71.92% | 983,000 -40.78% | 1.7M -14.30% | 1.9M -86.21% | |
Total Liabilities | 12.2M -8.99% | 13.4M +13.88% | 11.7M +55.44% | 7.5M +155.99% | |
Retained Earnings | -481.4M +19.21% | -403.9M +22.59% | -329.4M +26.23% | -261.0M +24.76% | |
Total Stockholders Equity | 100.7M -37.90% | 162.1M +33.99% | 121.0M +4.16% | 116.2M -22.28% | |
Total Shares Outstanding | 96.4M +10.82% | 87.0M +63.39% | 53.2M +44.58% | 36.8M +9.66% | |
Cash Flow | |||||
Cash from Operating Activities | -64.6M -6.43% | -69.1M +20.41% | -57.4M +28.97% | -44.5M +12.28% | |
Capital Expenditures | N/A N/A | N/A N/A | 153,000 0.00% | 153,000 N/A | |
Cash from Investing Activities | -21.1M +45.09% | -14.5M -129.86% | 48.7M +148.00% | -101.5M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.2M -97.91% | 107.3M +70.28% | 63.0M +444.72% | 11.6M -92.23% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -53.82% +11.46% | -48.28% -9.56% | -53.39% +42.34% | -37.51% -10.92% | |
Return on Equity | -59.04% +12.33% | -52.56% -8.95% | -57.73% +48.06% | -38.99% -16.64% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 9.68 -32.63% | 14.37 +7.28% | 13.39 -33.62% | 20.18 -67.34% | |
Cash Ratio | 0.93 -88.23% | 7.90 +7.80% | 7.33 +137.64% | 3.08 -94.95% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow